Search

  • Select Article Type
  • Abstract Supplements
  • Blood Group Review
  • Call to Arms
  • Hypothesis
  • In Memoriam
  • Interview
  • Introduction
  • Letter to the Editor
  • Short Report
  • abstract
  • Abstracts
  • Article
  • book-review
  • case-report
  • case-study
  • Clinical Practice
  • Commentary
  • Conference Presentation
  • conference-report
  • congress-report
  • Correction
  • critical-appraisal
  • Editorial
  • Editorial Comment
  • Erratum
  • Events
  • Letter
  • Letter to Editor
  • mini-review
  • minireview
  • News
  • non-scientific
  • Obituary
  • original-paper
  • original-report
  • Original Research
  • Pictorial Review
  • Position Paper
  • Practice Report
  • Preface
  • Preliminary report
  • Product Review
  • rapid-communication
  • Report
  • research-article
  • Research Communicate
  • research-paper
  • Research Report
  • Review
  • review -article
  • review-article
  • review-paper
  • Review Paper
  • Sampling Methods
  • Scientific Commentary
  • short-communication
  • short-report
  • Student Essay
  • Varia
  • Welome
  • Select Journal
  • Journal Of Nematology
  • Immunohematology

 

Review | 21-April-2020

Review: Cromer and DAF: role in health and disease

The antigens of the Cromer blood group system are located on the protein decay-accelerating factor (DAF). This system consists of ten high-prevalence and three low-prevalence antigens; the molecular basis for all of these antigens is a single nucleotide polymorphism in the DAF gene. DAF is a 70,000-Da plasma membrane protein that is widely distributed on all blood cells and on endothelial and epithelial tissues. The physiological role of DAF is to inhibit the complement cascade at the level of

Douglas M. Lublin

Immunohematology, Volume 21 , ISSUE 2, 39–47

Article | 20-December-2020

Cromer-related blood group antigens and the glycosyl phosphatidylinositol-linked protein, decay-accelerating factor DAF (CD55)

Cromer-related blood group antigens are located on the complement regulatory glycoprotein, decay-accelerating factor (DAF). DAF is not detectable on red cells from individuals with a Cromernull phenotype (termed Inab), which is probably an inherited condition. DAF is also absent from a subpopulation of red cells (PNH III) from patients with paroxysmal nocturnal hemoglobinuria (PNH), an acquired hematological defect. PNH III red cells, like Inab cells, lack all the Cromer-related antigens

Marion Reid

Immunohematology, Volume 6 , ISSUE 2, 27–29

Review | 14-March-2020

The Cromer blood group system: a review

The antigens of the Cromer blood group system reside on decay-accelerating factor (DAF), a protein belonging to the regulators of complement activation family. The blood group system consists of 12 high-prevalence and three lowprevalence antigens. The molecular basis for the antigens is known, and with the exception of IFC, each antigen is the product of a single nucleotide change in the DAF gene and has been localized to one of the four complement control protein (CCP) domains on the DAF

Jill R. Storry, Marion E. Reid, Mark H. Yazer

Immunohematology, Volume 26 , ISSUE 3, 109–117

Article | 21-April-2020

Novel molecular basis of an Inab phenotype  

The Cromer blood group system consists of ten high-prevalence and three low-prevalence antigens carried on decay-accelerating factor (DAF). DAF is found in the cell membranes of RBCs, granulocytes,platelets,and lymphocytes and is widely represented in other body tissues. Sequence analyses of DNA were performed on a blood sample from a 91-year-old Japanese woman whose serum contained an alloantibody to a high-prevalence antigen in the Cromer blood group system (anti-IFC). A blood sample from her

Kim Hue-Roye, Vivien E. Powell, Gita Patel, Debra Lane, Mariska Maguire, Amy Chung, Marion E. Reid

Immunohematology, Volume 21 , ISSUE 2, 53–55

Article | 21-April-2020

Analysis of SERF in Thai blood donors

The Cromer blood group system consists of nine high-prevalence and three low-prevalence antigens carried on decay-accelerating factor (DAF). We recently described one of these Cromer highprevalence antigens,SERF,the absence of which was found in a Thai woman.The lack of SERF antigen in this proband was associated with a substitution of nucleotide 647C>T in exon 5 of DAF, which is predicted to be a change of proline to leucine at amino acid position 182 in short consensus repeat (SCR) 3 of

Poonsub Palacajornsuk, Kim Hue-Roye, Oytip Nathalang, Srisurang Tantimavanich, Sasitorn Bejrachandra, Marion Reid

Immunohematology, Volume 21 , ISSUE 2, 66–69

Review | 14-October-2020

The Cromer blood group system: a review

The antigens of the Cromer blood group system reside on decay accelerating factor (DAF), a protein belonging to the regulators of complement activation family. The blood group system consists of eight high-incidence antigens and three low-incidence antigens. The molecular basis for the antigens is known and, with the exception of IFC, each antigen is the product of a single nucleotide polymorphism in the DAF gene and has been localized to one of the four short consensus repeat regions on the

Jill R. Storry, Marion E. Reid

Immunohematology, Volume 18 , ISSUE 4, 95–103

Article | 17-November-2020

Identification of the Tcb allele of the Cromer blood group gene by PCR and RFLP analysis

The Cromer blood group antigens reside on the complement regulatory protein, decay-accelerating factor (DAF). The Cromer system comprises 10 antigens, 3 of which are of low incidence. When an individual is homozygous for the allele encoding one of these low-incidence antigens, they are liable to produce an antibody to the anti-thetical high-frequency antigen if challenged by pregnancy or transfusion. These antibodies are often difficult to identify, because of the lack of readily available

Manisha Udani, Nicole Anderson, Neeraja Rao, Marilyn J. Telen

Immunohematology, Volume 11 , ISSUE 1, 1–4

Article | 28-April-2020

Persistent anti-Dra in two pregnancies

The Drori (Dra) antigen is one of the ten high-prevalence antigens of the Cromer blood system, which are carried on decayaccelerating factor (DAF, CD55). The Dr(a–) phenotype was first described in a 48-year-old Jewish woman from Bukhara. Her serum contained an antibody to a high-prevalence antigen named anti-Dra. Most known individuals with the Dr(a–) phenotype are Jews from the geographic area of Bukhara, but individuals from Japan have also been described. Antibodies in the

Naomi Rahimi-Levene, Abraham Kornberg, Gabriela Siegel, Valery Morozov, Eilat Shinar, Orna Asher, Cyril Levene, Vered Yahalom

Immunohematology, Volume 21 , ISSUE 3, 126–128

research-article | 30-November-2019

Detoxification-related gene expression accompanies anhydrobiosis in the foliar nematode (Aphelenchoides fragariae)

nhr-48 was upregulated despite its low expression. Additionally, DAF-12 (C. elegans), NHR-8, and DHR96 are involved in metabolism of steroid hormone, cholesterol, and triacylgylceride, which are related to healthy aging (King-Jones et al., 2006; Bujold et al., 2010; Horner et al., 2009; Antebi, 2013; Magner et al., 2013; Wang et al., 2015). Desiccated nematodes undergo extended life span, and it is critical to maintain health during such process. Our data have shown that genes that are key to

Zhen Fu, Paula Agudelo, Christina E. Wells

Journal of Nematology, Volume 52 , 1–12

Review | 26-October-2020

Laboratory diagnosis of paroxysmal nocturnal hemoglobinuria: a review

Marion E. Reid, Htun Min, Seshadri D. Thirumala

Immunohematology, Volume 15 , ISSUE 4, 144–149

No Record Found..
Page Actions